NCT04981509 2026-03-18
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
1 trialsHereditary leiomyomatosis and renal cell cancer × Magnetic Resonance Spectroscopy × 90 days × Clear all